Stablecoin Development Corp
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On June 29, 2023, Dr. Audrey Kunin advised NovaBay Pharmaceuticals, Inc. (the “Company”) of her decision to retire and resign from her position as the Company’s Chief Product Officer effective as of November 5, 2023, the natural expiration of her Executive Employment Agreement, dated November 5, 2021.
Extracted from this filing and checked against the source text.
Dr. Audrey Kunin resigned as Chief Product Officer at Stablecoin Development Corp.
On June 29, 2023, Dr. Audrey Kunin advised NovaBay Pharmaceuticals, Inc. (the “Company”) of her decision to retire and resign from her position as the Company’s Chief Product Officer effective as of November 5, 2023, the natural expiration of her Executive Employment Agreement, dated November 5, 2021.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.